- CA$2.75bn
- CA$6.29bn
- CA$1.02bn
- 77
- 51
- 39
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 574 | 633 | 691 | 836 | 1,022 |
Cost of Revenue | |||||
Gross Profit | 447 | 482 | 538 | 578 | 642 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 484 | 472 | 513 | 728 | 799 |
Operating Profit | 90 | 161 | 178 | 108 | 223 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -48 | 66 | 44 | 18 | 154 |
Provision for Income Taxes | |||||
Net Income After Taxes | -43 | 61 | 26 | 8 | 115 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -39 | 55 | 17 | 30 | 78 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -39 | 55 | 17 | 30 | 78 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.036 | 0.727 | 0.211 | 0.677 | 0.926 |
Dividends per Share |